Company Quick10K Filing
Creative Medical Technology
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-13
10-Q 2019-03-31 Filed 2019-05-20
10-K 2018-12-31 Filed 2019-04-01
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-21
10-K 2017-12-31 Filed 2018-03-29
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-10
10-K 2016-12-31 Filed 2017-02-13
10-Q 2016-09-30 Filed 2016-11-10
10-Q 2016-06-30 Filed 2016-08-19
10-Q 2016-03-31 Filed 2016-05-13
10-K 2015-12-31 Filed 2016-04-14
10-Q 2015-09-30 Filed 2015-11-09
10-Q 2015-06-30 Filed 2015-08-13
10-Q 2015-03-31 Filed 2015-05-08
10-K 2014-12-31 Filed 2015-02-27
10-Q 2014-09-30 Filed 2014-11-12
10-Q 2014-06-30 Filed 2014-08-08
10-Q 2014-03-31 Filed 2014-05-13
10-K 2013-12-31 Filed 2014-03-17
10-Q 2013-09-30 Filed 2013-11-13
10-Q 2013-06-30 Filed 2013-08-07
10-Q 2013-03-31 Filed 2013-05-07
10-K 2012-12-31 Filed 2013-03-15
10-Q 2012-09-30 Filed 2012-11-07
10-Q 2012-06-30 Filed 2012-08-09
10-Q 2012-03-31 Filed 2012-05-11
10-K 2011-12-31 Filed 2012-03-26
10-Q 2011-09-30 Filed 2011-10-31
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-03-31
10-Q 2010-09-30 Filed 2010-10-19
10-Q 2010-06-30 Filed 2010-08-12
10-Q 2010-03-31 Filed 2010-05-07
10-K 2009-12-31 Filed 2010-02-03
8-K 2020-03-19 Shareholder Rights, Amend Bylaw, Exhibits
8-K 2020-01-28 Shareholder Rights, Amend Bylaw, Exhibits
8-K 2019-10-11
8-K 2019-09-04 Other Events, Exhibits
8-K 2019-07-24 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2019-07-02 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2019-06-20 Other Events, Exhibits
8-K 2019-04-30 Other Events, Exhibits
8-K 2019-03-28 Other Events, Exhibits
8-K 2019-02-28 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2019-02-12 Other Events, Exhibits
8-K 2018-12-27 Other Events, Exhibits
8-K 2018-11-21 Enter Agreement
8-K 2018-11-06 Other Events, Exhibits
8-K 2018-10-17 Enter Agreement, Other Events, Exhibits
8-K 2018-09-20 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2018-08-14 Other Events, Exhibits
8-K 2018-08-08 Other Events, Exhibits
8-K 2018-07-19 Other Events, Exhibits
8-K 2018-07-06 Other Events, Exhibits
8-K 2018-06-19 Other Events, Exhibits
8-K 2018-05-23 Other Events, Exhibits
8-K 2018-05-08 Other Events, Exhibits
8-K 2018-04-30 Other Events, Exhibits
8-K 2018-04-26 Sale of Shares
8-K 2018-04-26 Sale of Shares
8-K 2018-04-12 Sale of Shares
8-K 2018-04-11 Enter Agreement, Sale of Shares, Other Events, Exhibits
8-K 2018-03-26 Other Events, Exhibits
8-K 2018-03-15 Sale of Shares
8-K 2018-02-22 Amend Bylaw, Exhibits
8-K 2018-02-01 Other Events, Exhibits
8-K 2018-01-12 Enter Agreement, Amend Bylaw, Exhibits
8-K 2018-01-09 Shareholder Vote
8-K 2018-01-05 Sale of Shares
8-K 2017-12-29 Sale of Shares

Creative Medical Technology Financials

CELZ Metrics, Comps, Filings

Quarterly | Annual

Business

We were incorporated on December 3, 1998, in the State of Nevada, and have one wholly-owned subsidiary, Creative Medical Technologies, Inc., a Nevada corporation (“ CMT ”), which conducts all of our business operations. On September 14, 2016, we formed a limited liability company, Amniostem LLC Inc., in Nevada for the purpose of creating and/or licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. This entity is a wholly owned subsidiary of CMT but has not commenced any business activities. In May 2017, we formed StemSpine, LLC (“ StemSpine ”), in Nevada for the purpose of creating and/or licensing intellectual property in the area of utilizing stem cells to treat lower back pain. This entity is a wholly owned subsidiary of CMT but has not commenced any business activities. In June 2018, we formed CaverStem International, LLC, in Nevada for the purpose of licensing the CaverStem procedure internationally. This entity is 60% owned by Creative Medical Technology Holdings, Inc. and 40% owned by Dr. Alex Gershman. It has not commenced any business activities.

Our principal executive offices are located at 3008 W Lupine, Phoenix, AZ 85029.

CMT was created as the urological arm of its parent company, Creative Medical Health, Inc. (“CMH”), to monetize the treatments or products developed or acquired by CMH prior to creation of CMT and transferred to it after its incorporation. CMT acquired a patent for its erectile dysfunction (“ ED ”) treatment from CMH. Subsequent to the transfer, CMT has expanded its development and acquisition of intellectual property beyond urology to include therapeutic treatments utilizing amniotic stem cells and treatment of neurologic disorders and lower back pain using various types of stem cells.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarterly)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarterly)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
NioCorp Developments (NIOBF) 0.0 -62% 10,720 6,057 0 0 -6,610 -6,383 -46
Sunvalley Solar (SUNV) 16% 0.6 -181,286,500% 3,031 494 1,813 1,819 1,020
Mikrocoze (MRCZ) 0.0 1,881,700% 0 0 -19 -19 -0
Credex (CRDX) 0.0 0 72 0 0 -7 -7 -0
Skinovation Pharmaceutical (SKIN) 0.0 -24,889% 0 307 0 0 -23 -11 -0
Nestor Partners (C471) 0% 155,359 2,907 0 0 0 0 -12,534
Adveco Group (ADVV) 14% 0.0 -38% 9,267 21,482 1,743 247 -3,565 -3,562 -0
Digital Development Partners (DGDM) 0.0 -5,818% 2 1,110 0 0 -89 -58 -2
Creative Medical Technology (CELZ) 76% -0.8 -996% 330 3,893 170 128 -3,292 -1,804 1,374
Altegris Qim Futures Fund (AQIM) 0.5 -15% 13,755 1,750 0 0 -2,052 -2,047 -1,008
Global House Holdings (KLDK) 0.0 -179% 20 84 0 0 -36 -36 -0
Athena Silver (AHNR) -0.7 -115% 189 3,024 0 0 -217 -134 90
Potomac Futures Fund (POTO) -1.7 15% 39,002 765 0 0 5,745 5,745 -9,851
AEI Income & Growth Fund 26 (AEI26) 1.4 -8% 9,648 362 0 0 -791 -496 -671
General Motors Financial (ACF) 0% 17.9 1% 109,361,000 96,673,000 14,517,000 0 1,508,000 4,702,000 84,241,000
Markham Woods (MWPP) 0.2 16,188,400% 0 0 -162 -46 -9
Williams Partners (WPZ) 0% 5.1 2% 45,938,000 24,399,000 8,277,000 0 775,000 3,293,000 16,763,000
8i Enterprises Acquisition Corp (JFKKU)
American Cryostem (FIL) 84% 0.1 -83% 1,201 2,367 172 144 -991 -918 -54
Cleantech Biofuels (CLTH) 0.0 -13% 2,188 7,443 0 0 -290 -22 -0

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash11111110001111111002633222981042114102101173304419204158
Accounts Receivable510514100124
Inventory
PP&E
Assets4321122000111111100122137323196300211203291279356477578358330
Accounts Payable3888810107881210111013111317202645669753157238233273243332343320324
Long-Term Debt4937576739881,9921,6461,533
Liabilities707583931251541691761841713734724804961,3221,2842,4398,22510,8717,7104,4724,1832,9953,893
Stockholders' Equity-65-72-81-92-125-153-184-335-158-2,236-7,354-3,995-3,605-2,637-3,563
Income Statement ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue0000000000000000000000005101452516258
Cost of Revenue233614198
Gross Profit7216374250
R&D18451860258887343000
SG&A188165172178382202150203309283282313318
Tax0000000000000-00000000000000000
Net Income-5-7-9-5-6-6-10-6-5-6-10-6-6-7-9-6-6-9-5-209-215-194-243-886-52-1,477-7,587-6,432-1,571-797-88-2,406
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-7-3-4-9-6-4-4-4-5-3-5-5-5-2-20-121-185-224-269-123-165-245-347-273-329-358
Cash Investing00000000000000000-1000-100000
Cash Financing06249644553555210139374100376115254243419388114312